CIRM Awards

In November 2004, California voters approved Proposition 71, which established the California Institute for Regenerative Medicine (CIRM) and authorized the issuance of $3 billion in state general obligation bonds to provide funding for stem cell research and facilities in California. CIRM’s mission is to accelerate stem cell treatments to patients with unmet medical needs. In 2020, California voters approved Proposition 14, which provided an additional $5.5 billion in funding for CIRM. 

To date, UCLA and its stem cell scientists have received 151 grants from CIRM totaling more than $407 million.

You can see find a full list of all CIRM grants to UCLA in the agency's awards dashboard.